ABSTRACT
1 0 via Fisher's method is the most robust at the cost of slightly reduced power. We applied both atherosclerosis (MESA; n=2,073). Consistent with previous eQTL findings on mean, we found 1 5 some but not conclusive evidence for cis regulators being enriched for variance association.
6
Individual SNP rs148191803 was X-chromosome-wide significant for waist circumference 1 7 (p=2.4E-6) and suggestive for BMI (p=1.2E-5) in UKB but not in MESA. However, a 1 8 permutation study based on MESA showed a trait-specific polygenic model whereby multiple X-1 9 chromosome loci collectively influence variance of height (ߣ ீ =1.14, p<1/100), calling for 2 0 developments of methods to examine broad-sense heritability by incorporating variance loci and 2 1 quantifying their sex-specific contributions. direct GxE modeling may not be feasible in an initial whole-genome scan, the question was then follow-up interaction testing 3 . For instance, rs7202116 (FTO as the nearest gene) was
X-chromosome (XCHR) specific challenges for variance tests 1
The same approach to draw similar conclusions for XCHR SNPs, however, is questionable, 2 because Pr(S|G = g) is no longer constant in G and expression (3) cannot be further reduced to 3 (4). For example, under the X-inactivation coding of 0, 1 and 2 for the bb, Bb and BB genotypes 4 in females and 0 and 2 for the b and B genotypes in males, the G=1 group contains only females.
5
Similarly, under the no X-inactivation coding of 0, 1 and 2 for females and 0 and 1 for males, the 6 G=2 group then contains only females. Thus, omitting the sex indicator S from the covariates 7 can bias the conclusion through sexual dimorphism as seen in Figure 1 .
8
Consider the simplest case of no interaction effects at all (β GS = phenotypic means differ between males and females), then expression (3) is reduced to
1 2
Thus, in the absence of any interactions that involve G, there is a spurious phenotypic variance 1 3 heterogeneity across levels of G through a non-zero sex main effect ( (either in mean- Figure 2B or variance- Figure 2C or both- Figure 2D ), there would be spurious 1 variance heterogeneity resulting in increased false positive rates (also confirmed by empirical 2 results).
3
As an alternative, one may be tempted to treat each genotype and sex combination as one 4 group, resulting in a total of 5 groups. Indeed, this five-group strategy does not induce spurious 5 association in the presence of sex-specific mean effect (ߤ ് ߤ as in Figure 2B Stage One: Mean models,
Stage Two: Variance models,
The models in stage one are only used to calculate residuals, using either the traditional 2 2 ordinary least squares (OLS) or the recommended least absolute deviations (LAD); LAD is more in simulation studies then focused on the robust approaches in applications. A sample of 2,500 females and 2,500 males were simulated, and the MAF was fixed at 0.2; other 1 7
sample sizes and MAFs led to qualitatively similar results. Note that although G could be coded
assuming X-inactivation or no X-inactivation, the two types of coding are generally highly rate of 5% were considered satisfactory. A joint mean and variance test can be more powerful than testing for variance 1 heterogeneity alone, but the power of the joint test depends on the individual components 10 .
2 Therefore, here we focus on comparing the different variance-testing strategies as outlined 3 above, recommending the most robust yet powerful method that is also suitable for the joint 4 location-scale test.
6
Simulations for T1E evaluation -design I based on model (1) 7
The genotype-phenotype relationship was generated according to model (1), where the by the absence of interaction effects for GxE and GxExS, so the quantitative trait for each null
scenario was generated assuming
effect, but it does not affect the phenotypic variance of interest which is induced by un-modeled variance methods could also pick up a non-zero GxS interaction effect if
in fact can be directly tested because gender information is routinely collected (or robustly 1 6
inferred from the available genotype data). Thus,
is not related to the variance heterogeneity 1 7
of interest here and was set to be zero. For the remaining parameters, without loss of generality, They roughly fall into four categories, corresponding to the four conceptual sex-stratified are independent of the genotype-specific variance effect to be identified, which is absent in 1 the null cases. Only strategies with satisfactory T1E control were considered for power evaluation. We focused interaction effects and has a clearer genetic interpretation than design II. Under model (1),
was varied from 0 to 0.2 with a 0.025 incremental increase, and combined with a possible three- Robust variance testing strategies for X-chromosome SNPs that also had reasonable power The significance level for discovery was set at a nominal level of 5% with Bonferroni 7 correction, depending on the total number of XCHR SNPs examined in each application.
8
Further, the proportion of truly variance-associated variants was estimated using the method 9
proposed by Storey and Tibshirani 41 . Available genotyped XCHR SNPs were filtered based on whether they were in pseudo analyzed, and the XCHR-wide significance level was 6.8E-6. The Multi-Ethnic Study of Atherosclerosis (MESA) data 32 .
The genotype data in MESA, available from dbGap (Study accession: phs000209.v10.p2), were
filtered similarly as the UKB data. In total, 12,206 XCHR SNPs on the Caucasian sample (1,003 2 0 females and 1,070 males) were analyzed, and the XCHR-wide significance level was 4.1E-6.
1
We did not perform a multi-ethnic analysis with all ethnicities combined. Instead, we focused on 2 2
the Caucasian subset and used it to corroborate findings from the UKB data. resulting in a total number of 2,614,032 tests and a global significance level of 1.9E-8. As expected, the naïve Levene's test with either a three-level factor G factor or a five-level GxS were all set to zero or the in the absence of any sexual dimorphism (Table 1) . behave quite similarly (Table S3) .
The sex-stratified approach, as expected, gave correct T1E rates in females and males 2 separately, and subsequently in the combined sample via Fisher's methods, under both design I 3 (Table 1 ) and design II (Table S3) . consistent ( Figure S2 , Table S4 ). Thus, we recommend the M3V3.2 model-based approach and 1 4 the complementary sex-stratified Fisher's method, which were then applied to the three 1 5 application datasets. UKB (Table S5) , rs148191803 (MED14; in a region known to escape X-inactivation) was found (Table S6 ).
8
Although there were no additional X-chromosome-wide significant SNPs in UKB or 9 MESA, the overall distributions of the p-values suggest enrichment of associated variants for 1 0 some of the traits. In Figure S4 for example, the estimated genomic lambda SNPs also suggested signal enrichment (Table S7) .
4
To benchmark the observed estimates, a permutation analysis was conducted using the permutated within the two sex strata, independently, 100 times. For each permutated dataset,
Fisher's method and M3V3.2 were applied and the corresponding variance of height. The same conclusion holds, but to a lesser extent for waist circumference.
2
However, for hip circumference and BMI, the observed estimates were not visibly different from on the estimated proportion of truly associated SNPs ( Figure S6 ).
For the eQTL analysis, we observed various forms of sexual dimorphism in expression 3 traits. In total, 182 out of the 648 expression traits had p <0.05 based on either a t-test of 4 equality of means or an F-test for equality of variance between the two sexes ( Figure S7 ).
5
Among the eQTLs, the top five variance-associated SNPs belonged to three genes, FTX, PLAC1 6 and TEX11 (Figures S8-10 ), but no SNPs passed the strict Bonferroni correction at p < 1.9E-8 7 (Table S8 ). There was no apparent enrichment of association globally over all SNP-expression needed to establish convincing evidence for enrichment of variance-associated eQTLs. This work was motivated by the recent call to include X-chromosome (XCHR) in 'whole- with phenotypic variance 1, 20 . To pave the way for future XCHR-wide study of variance 2 2 heterogeneity and subsequent joint location-scale test 10 , we examined a catalogue of analytical 2 3 1 9 strategies and recommended two robust and power approaches. We emphasize the importance of 1 recognizing sex as an inherent confounder in analyzing XCHR variants that contribute to 2 phenotypic variance heterogeneity, particularly for traits displaying sexual dimorphism with 3 either sex-specific means or variances, or both; this also holds for the traditional association 4 analysis of XCHR variants studying their effects on phenotypic mean 22 .
Between the two recommended strategies, Fisher's method to combine sex-specific 6
Levene's p-values is intuitive and the most robust, but at the cost of slightly reduced power. recommend in practice to apply both methods to complement each other.
2
The naïve strategies that directly test for variance heterogeneity across either the classical rates in the presence of any sexual dimorphism ( Table 1 ). Note that if the status of X- underlying X-inactivation status (Table S4) . Though in applications, the genetic main effect the GxS interaction term is included in the model, which explains the consistent performance of
M3V3.2 irrespective of the X-inactivation status.
7
Since variance testing requires larger sample size than mean testing, detecting individual loci as well as quantify their contributions to sex-specific heritability. Supplemental data include 13 figures, 8 tables, and theoretical derivations. 
